November 12, 2013 - ZOLL Technology for Improving CPR Quality to Be Showcased at AHA Annual Conference


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
[email protected]



Fourteen Scientific Presentations Related to ZOLL Technology Scheduled at ReSS  

November 12, 2013—CHELMSFORD, MASS.—ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its advanced resuscitation technology, which supports the American Heart Association’s increased focus on improving CPR quality to improve survival from sudden cardiac arrest (SCA), will be on display during the American Heart Association (AHA) 2013 Resuscitation Science Symposium (ReSS) and Scientific Sessions in Booth #1333 November 17-19 in Dallas.

Improving CPR quality has been an ongoing commitment of ZOLL’s since 2002, when it was the first to introduce real-time CPR feedback in a defibrillator, its AED Plus®. Today, virtually all ZOLL defibrillators, from AEDs to professional manual defibrillators, feature Real CPR Help®, the only CPR-feedback technology that has been shown to impact survival-to-discharge, as demonstrated in published research.1

ZOLL’s commitment to high-quality CPR is also evident in the company’s suite of tools for optimal resuscitation response, which includes See-Thru CPR® as well as EtCO2 monitoring. See-Thru CPR, ZOLL’s proprietary technology which minimizes the duration of pauses in CPR to enable rescuers to see an organized, underlying rhythm, is available on the R Series®, the X Series®, and the AED Pro®.

Advanced Resuscitation Solutions from ZOLL

Highlights among ZOLL’s clinical portfolio in booth 1333 include:

  • The R Series® Code-Ready® defibrillators are designed to extend “Simple, Smart and Ready” defibrillation to every hospital department through advanced, cost-effective solutions for resuscitation.
  • The X Series® Monitor/Defibrillator is ideal for transporting critically ill patients. It is lightweight with extensive monitoring capabilities.
  • OneStep™ Pediatric CPR Electrodes are the only electrodes on the market with a built-in CPR sensor that reports CPR quality on young children up to 8 years of age. This first-of-its-kind electrode provides optimal support for pediatric resuscitation when paired with the ZOLL R Series® Monitor/Defibrillator and its CPR Dashboard™.
  • The AutoPulse® Non-Invasive Cardiac Support Pump is an automated, portable chest compression device. It is the only mechanical CPR system to have shown improved survival in comparative clinical trials. The AutoPulse more than tripled survival compared to typical CPR during witnessed shockable arrests.2 Most recently a meta-analysis of available clinical findings found that the likelihood of circulation returning was 62% higher with use of the AutoPulse when compared to manual compressions, while a parallel analysis showed no significant change with a conventional piston-driven device.3 
  • The LifeVest® Wearable Defibrillator is worn by patients at risk for sudden cardiac arrest (SCA), providing protection during their changing condition and while permanent SCA risk has not been established. The LifeVest continuously monitors the patient’s heart and, if a life-threatening heart rhythm is detected, the device delivers a treatment shock to restore normal heart rhythm. The LifeVest is lightweight and easy to wear, and allows a patient’s physician time to assess his or her long-term arrhythmic risk and make appropriate plans.
  • ZOLL’s Intravascular Temperature Management (IVTM™) system offers health care providers the power and control they need to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients. The Thermogard XP® delivers accurate, easy-to-use and cost-effective control for both cooling and warming applications. The temperature management system provides a variety of catheter options depending upon the specific patient needs.

Scientific Presentations Related to ZOLL Products and Technology

Fourteen scientific presentations related to ZOLL products and technology are scheduled to be presented during ReSS. Key presentations held Central time are:

  • Qing Tan, PhD, will present “Accurate ECG Interpretation with Use of the Analysis during Compressions with Fast Reconfirmation (ADC-FR) Technology,” Sunday, November 17 at 7:00 - 8:30 a.m. in the Omni Hotel Dallas Ballroom D-H. Poster 252.
  • Christopher Crowe, MD, will present “Improvements in Emergency Department CPR Quality Utilizing Real-Tim Audiovisual CPR Feedback,” Sunday, November 17 at 7:00 - 8:30 a.m. in the Omni Hotel Dallas Ballroom D-H. Poster 268.
  • Tyler Vadeboncoeur, MD, will present “Use of Real-Time Audiovisual CPR Feedback is Associated with Improved CPR Quality during Patient Transfer from the Scene to Ambulance in Out-of-Hospital Cardiac Arrest,” Sunday, November 17 at 7:00 - 8:30 a.m. in the Omni Hotel Dallas Ballroom D-H. Poster 306.
  • Chingping Wan, MD, ZOLL, will present “Hospital Personnel Interactions With Wearable Cardioverter Defibrillators During Sudden Cardiac Arrest: A Case Series Review,” Sunday, November 17 at 7:00 - 8:30 a.m. in the Omni Hotel Dallas Ballroom D-H. Poster 312.

A listing and schedule of the ZOLL-related presentations is available at All presentations will be available from the AHA and ZOLL at the conclusion of the AHA Scientific Sessions program.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 29,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit

Copyright © 2013 ZOLL Medical Corporation. All rights reserved. AED Pro, AutoPulse, Code-Ready, CPR Dashboard, IVTM, LifeVest, OneStep, Real CPR Help, R Series, See-Thru CPR, X Series, Thermogard XP, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All product names are the property of their respective owners.

1Bobrow BJ, et al. Ann Emerg Med. 2013 Jul;62(1):47–56.e1. Epub 2013 Mar 7.
2Wik L, et al. The impact of CPR duration on survival to discharge between integrated AutoPulse-CPR and manual–CPR during out-of-hospital cardiac arrest of presumed cardiac origin. Resuscitation. 2012;83:e17
3Westfall et al. Mechanical versus manual chest compressions in out-of-hospital-cardiac arrest. Critical Care Medicine. 2013;41:1-7.